Allergan, an AbbVie company, announced the FDA approval of the eye drop, Vuity, for the treatment of presbyopia.
The approval for the pilocarpine HCl ophthalmic solution 1.25% was granted Oct. 28, according to the FDA’s website.
“"We are proud to offer Vuity as a first-of-its-kind once-daily eye drop that we believe will change the way people and their eye doctors approach presbyopia,” Michael Severino, MD, Abbvie vice chairman and president, said in a press release from the company.
This daily prescription eye drop takes effect in as little as 15 minutes and can last up to 6